Cell Line : KMS-21-BM
Cellosaurus Index : CVCL_2991
Cellosaurus ID : KMS-21-BM
CTRP2 Name
: KMS21BM
CCLE Name
: KMS21BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| KMS-21-BM | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | 968 | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-21-BM | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| KMS-21-BM | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Bax channel blocker | CTRP2 | 0.0160 | 33.0000 |
|
| KMS-21-BM | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BIX-01294 | CTRP2 | 0.0160 | 33.0000 |
|
| KMS-21-BM | blebbistatin | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| KMS-21-BM | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| KMS-21-BM | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K03911514 | CTRP2 | 0.0020 | 17.0000 |
|
| KMS-21-BM | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| KMS-21-BM | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K58730230 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| KMS-21-BM | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| KMS-21-BM | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| KMS-21-BM | BRD4770 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| KMS-21-BM | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| KMS-21-BM | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| KMS-21-BM | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| KMS-21-BM | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| KMS-21-BM | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| KMS-21-BM | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| KMS-21-BM | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| KMS-21-BM | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-21-BM | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Daporinad | CTRP2 | 0.0000 | 0.2600 |
|
| KMS-21-BM | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| KMS-21-BM | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| KMS-21-BM | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| KMS-21-BM | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | Fulvestrant | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| KMS-21-BM | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| KMS-21-BM | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Linifanib | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-21-BM | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | ML162 | CTRP2 | 0.0650 | 33.0000 |
|
| KMS-21-BM | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| KMS-21-BM | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-21-BM | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | NSC632839 | CTRP2 | 0.0160 | 33.0000 |
|
| KMS-21-BM | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| KMS-21-BM | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| KMS-21-BM | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | Oxaliplatin | CTRP2 | 0.0320 | 66.0000 |
|
| KMS-21-BM | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| KMS-21-BM | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| KMS-21-BM | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-21-BM | PRIMA-1MET | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| KMS-21-BM | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Regorafenib | CTRP2 | 0.0320 | 66.0000 |
|
| KMS-21-BM | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| KMS-21-BM | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| KMS-21-BM | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-21-BM | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-21-BM | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-21-BM | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-21-BM | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-21-BM | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-21-BM | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-21-BM | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| KMS-21-BM | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| KMS-21-BM | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-21-BM | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| KMS-21-BM | SNS-032 | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-21-BM | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-21-BM | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Staurosporine | CTRP2 | 0.0260 | 3.3000 |
|
| KMS-21-BM | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-21-BM | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| KMS-21-BM | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| KMS-21-BM | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-21-BM | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-21-BM | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| KMS-21-BM | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | TW 37 | CTRP2 | 0.0010 | 8.3000 |
|
| KMS-21-BM | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| KMS-21-BM | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| KMS-21-BM | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-21-BM | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-21-BM | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-21-BM | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-21-BM | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| KMS-21-BM | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC